Apollo Endosurgery PE Ratio 2006-2018 | APEN

Current and historical p/e ratio for Apollo Endosurgery (APEN) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Apollo Endosurgery PE ratio as of March 22, 2019 is 0.00.
Apollo Endosurgery PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-03-22 4.00 0.00
2018-12-31 3.45 $-1.45 0.00
2018-09-30 7.17 $-1.87 0.00
2018-06-30 6.98 $-1.74 0.00
2018-03-31 6.27 $-1.85 0.00
2017-12-31 5.60 $-2.15 0.00
2017-09-30 4.68 $-36.74 0.00
2017-06-30 7.89 $-36.42 0.00
2017-03-31 12.52 $-41.89 0.00
2016-12-31 12.16 $-45.74 0.00
2016-09-30 18.04 $-15.35 0.00
2016-06-30 11.99 $-21.51 0.00
2016-03-31 14.32 $-15.41 0.00
2015-12-31 17.49 $-21.57 0.00
2015-09-30 14.70 $-43.14 0.00
2015-06-30 21.25 $-52.39 0.00
2015-03-31 190.19 $-70.11 0.00
2014-12-31 217.14 $-77.04 0.00
2014-09-30 271.04 $-50.85 0.00
2014-06-30 305.69 $-35.44 0.00
2014-03-31 365.75 $-17.72 0.00
2013-12-31 328.02 0 0.00
2013-09-30 429.66 0 0.00
2013-06-30 338.80 0 0.00
2013-03-31 386.54 0 0.00
2012-12-31 388.85 $5.39 72.13
2012-09-30 398.86 $5.39 73.98
2012-06-30 404.25 $5.39 74.98
2012-03-31 415.03 $5.39 76.98
2011-12-31 641.41 0 0.00
2011-09-30 458.15 0 0.00
2011-06-30 528.22 0 0.00
2011-03-31 636.02 $-10.78 0.00
2010-12-31 479.71 $-5.39 0.00
2010-09-30 485.10 $-5.39 0.00
2010-06-30 339.57 $64.69 5.25
2010-03-31 425.81 $37.74 11.28
2009-12-31 431.20 $37.74 11.43
2009-09-30 452.76 $21.56 21.00
2009-06-30 765.38 $-70.08 0.00
2009-03-31 506.66 $-59.30 0.00
2008-12-31 565.95 $-123.99 0.00
2008-09-30 517.44 $-107.82 0.00
2008-06-30 662.97 $-86.26 0.00
2008-03-31 970.20 $-59.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.088B $0.061B
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.261B 23.72
Intuitive Surgical (ISRG) United States $64.748B 60.48
Edwards Lifesciences (EW) United States $39.266B 40.21
Fresenius Medical Care AG KGaA (FMS) Germany $23.664B 16.20
IDEXX Laboratories (IDXX) United States $18.873B 51.39
ABIOMED (ABMD) United States $14.572B 96.19
Teleflex (TFX) United States $13.884B 30.44
Hologic (HOLX) United States $13.648B 20.64
Varian Medical Systems (VAR) United States $12.581B 31.43
DexCom (DXCM) United States $11.613B 444.93
STERIS (STE) United Kingdom $10.406B 26.74
Masimo (MASI) United States $7.109B 44.26
Penumbra (PEN) United States $5.474B 309.73
Integra LifeSciences Holdings (IART) United States $4.712B 22.85
Globus Medical (GMED) United States $4.682B 28.42
LivaNova (LIVN) United Kingdom $4.628B 28.53
Wright Medical Group (WMGI) Netherlands $3.980B 0.00
Tandem Diabetes Care (TNDM) United States $3.969B 0.00
Glaukos (GKOS) United States $2.896B 0.00
Cantel Medical (CMD) United States $2.757B 27.41
Integer Holdings (ITGR) United States $2.736B 22.32
Inogen (INGN) United States $1.966B 39.18
AVANOS MEDICAL, INC (AVNS) United States $1.941B 21.08
Nevro (NVRO) United States $1.885B 0.00
OPKO Health (OPK) United States $1.557B 0.00
Pacific Biosciences Of California (PACB) United States $1.102B 0.00
Accelerate Diagnostics (AXDX) United States $1.083B 0.00
Luminex (LMNX) United States $1.067B 48.73
ORTHOFIX MEDICAL INC (OFIX) United States $1.059B 28.78
Tactile Systems Technology (TCMD) United States $1.045B 198.46
CryoLife (CRY) United States $1.043B 112.44
Veracyte (VCYT) United States $1.006B 0.00
Intersect ENT (XENT) United States $0.968B 0.00
Fluidigm (FLDM) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.875B 35.79
Natus Medical (BABY) United States $0.851B 17.75
AngioDynamics (ANGO) United States $0.811B 26.30
ViewRay (VRAY) United States $0.808B 0.00
AxoGen (AXGN) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.654B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
TransEnterix (TRXC) United States $0.482B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.462B 48.72
Si-Bone (SIBN) United States $0.440B 0.00
Accuray (ARAY) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.412B 0.00
Corindus Vascular Robotics (CVRS) United States $0.390B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
RTI Surgical (RTIX) United States $0.357B 52.09
IRadimed (IRMD) United States $0.304B 64.19
SeaSpine Holdings (SPNE) United States $0.282B 0.00
Sientra (SIEN) United States $0.276B 0.00
Neuronetics (STIM) United States $0.262B 0.00
Nuvectra (NVTR) United States $0.206B 0.00
CRH Medical (CRHM) Canada $0.188B 43.67
ConforMIS (CFMS) United States $0.162B 0.00
Helius Medical Technologies (HSDT) United States $0.159B 0.00
Ekso Bionics Holdings (EKSO) United States $0.153B 0.00
T2 Biosystems (TTOO) United States $0.129B 0.00
Biosig Technologies (BSGM) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
SOLITON INC (SOLY) $0.114B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Vermillion (VRML) United States $0.103B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.050B 0.00
Electromed (ELMD) United States $0.045B 23.17
Viveve Medical (VIVE) United States $0.044B 0.00
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
Avinger (AVGR) United States $0.037B 0.00
OBALON THERPTCS (OBLN) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.028B 0.00
PAVmed (PAVM) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
Atossa Genetics (ATOS) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 66.67
Dynatronics (DYNT) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.016B 12.17
ReWalk Robotics (RWLK) Israel $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Neovasc (NVCN) Canada $0.012B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00